(S, R, S)-AHPC-C4-NH2 dihydrochloride 11554 ClH/c1-3-32-25(31)21(14-13-18-9-5-4-6-10-18)26-17(2)23(28)27-16-20-12-8-7-11-19(20)15-22(27)24(29)30

ClH/c1-3-32-25(31)21(14-13-18-9-5-4-6-10-18)26-17(2)23(28)27-16-20-12-8-7-11-19(20)15-22(27)24(29)30

in partnership with Abbott Laboratories and Kyowa Hakko Kirin

Xanthatin exhibits strong antitumor activities against a variety of cancer cells through apoptosis persuasion and shows anti-inflammatory activities by inhibiting PGE2 synthesis and 5-lipoxygenase activity

8:CD005494

is a dual antagonist of the A2aR and A2bR adenosine receptors

(S, R, S)-AHPC-C4-NH2 dihydrochloride 11554 ClH/c1-3-32-25(31)21(14-13-18-9-5-4-6-10-18)26-17(2)23(28)27-16-20-12-8-7-11-19(20)15-22(27)24(29)30(S,R,S) AHPC C4 NH2 dihydrochloride is a synthesized E3 ligase ligand linker conjugate that incorporates the (S,R,S) AHPC based VHL ligand and a linker used for EED Targeted PROTAC. Product information CAS Number: 2341796 78 7 Molecular Weight: 602. 62 Formula: C27H41Cl2N5O4S Chemical Name: (2S,4R) 1 [(2S) 2 (5 aminopentanamido) 3,3 dimethylbutanoyl] 4 hydroxy N {[4 (4 methyl 1,3 thiazol 5 yl)phenyl]methyl}pyrrolidine 2 carboxamide dihydrochloride